Washington D.C. – Food and Drug Administration (FDA) officials are slated to present data next week to the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP), alleging a link between COVID-19 vaccines and 25 pediatric deaths. This planned presentation has ignited concern among career scientists and public health experts, who emphasize that the data, reportedly sourced from the Vaccine Adverse Event Reporting System (VAERS), does not establish causation.
The Vaccine Adverse Event Reporting System (VAERS) is a publicly accessible database where anyone can submit reports of adverse events following vaccination, but these reports are unverified and cannot, by themselves, prove a causal connection. Health agencies utilize VAERS to identify potential safety signals for further investigation, not as definitive evidence of vaccine-related harm. Critics argue that the planned presentation risks misinterpreting the database.
Several studies have consistently affirmed the safety and efficacy of COVID-19 vaccines in children. A 2023 analysis in JAMA Pediatrics reviewed 17 studies involving over 10 million vaccinated children aged 5 to 11, finding that mRNA shots reduced infection and hospitalization risks. Another 2024 study in Nature Communications found no increased risk of adverse events in young children, noting only a small, elevated risk of myocarditis in male teens after initial doses.
The context of this announcement includes recent leadership changes at the Department of Health and Human Services (HHS) under Secretary Robert F. Kennedy Jr., a known vaccine critic. Kennedy Jr. recently replaced ACIP members, appointing individuals with similar views, which the American Academy of Pediatrics described as a "radical departure" from the committee's mission. This has led to concerns about political influence on vaccine recommendations.
While the FDA investigates these VAERS reports, the CDC has previously presented data indicating that at least 25 children died from COVID-associated hospitalizations since July 2023. Of the 16 children old enough for vaccination in that group, none were up to date on their COVID-19 vaccines, highlighting the protective benefits of immunization against severe outcomes from the virus itself. The upcoming ACIP meeting is critical as its recommendations influence vaccine access and coverage.